Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy
NCT ID: NCT06947889
Last Updated: 2025-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
11 participants
OBSERVATIONAL
2024-07-01
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* wearable technology (smartwatch), from which the HRV (Heart Rate Variability) signal will be measured;
* infrared thermography, from which the temperature in salient facial regions will be obtained;
* fNIRS (functional near-infrared spectroscopy), from which information on brain activity and its changes over time will be obtained.
Information on the kinematics of the exoskeleton used during RAGT will be extracted.
The RAGT will be performed using the Lokomat orthosis (Hocoma), the most widely used exoskeleton in rehabilitation that facilitates a bilaterally symmetrical gait, as the individual actively tries to advance each limb during walking, combined with a patented dynamic body weight support system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Synergies During Gait in Children With Cerebral Palsy Undergoing Robot-assisted Gait Therapy
NCT06156969
Gait Adaptation and Biofeedback for Cerebral Palsy
NCT05899153
Robot Assisted Gait Training In Children With Cerebral Palsy
NCT05540990
The Effect of Robot-assisted Gait Training on Gait Ability in Children With Cerebral Palsy Through Changing Gait Speed
NCT04909151
Robotic-assisted Therapy to Improve Manual Dexterity in Children With Cerebral Palsy
NCT02923167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The protocol consists of a block paradigm: children will be asked to actively move during the robotic training for the first 30 seconds, followed by a rest period of 30 seconds. The paradigm will be provided in 10 blocks for a total duration of 30 minutes. During each single session, infrared (IR) thermal video, smartwatch signals (HRV- heart rate variability) and the kinematic output of the robot will be recorded. During the first (T1) and the last session of the RAGT (T12), fNIRS will also be recorded together with the assessment of motor skills, revealed by clinical scales. The assessment of fNIRS and clinical scales will be useful to understand the global efficacy of the treatment. Before the start of the experimental trials, parents will be extensively informed about the purpose and protocol of the study and will sign an informed consent form.
For each session, the assessment of the psychophysiological state of the patients will be based on the estimation of the state of physiological parameters, such as heart rate variability (HRV), recorded by a smartwatch and on the assessment of the emotional state of the child by means of an infrared thermal imaging system. The information on the state of the child and the robot will be assessed in real time and will constitute the input data for a machine learning-based model capable of classifying the level of patient engagement. Based on this information, the physiotherapist, who assists the child during the training sessions, will be able to intervene and modify the parameters of the exoskeleton (e.g. push force, body weight support, treadmill speed, range of motion and hip and knee offset). Furthermore, the effectiveness of the entire treatment will be assessed through the administration of clinical tools commonly used in clinical practice and by the assessment of brain activation by means of a non-invasive and portable neuroimaging technique, the fNIRS. These assessments will be conducted by comparing the first and the last training session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RAGT
Biofeedback based system development to enhance Robotic Assisted Gait Training in cerebral palsy pediatric patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* severe lower limb conditions: muscle contractures, instability or subluxation of the hip;
* recent botulinum toxin A injections to the lower limbs;
* uncontrolled seizures;
* open skin disorders and vascular disorders of the lower limbs.
* Contraindications to gait rehabilitation treatment with Lokomat (e.g. weight \<10 kg, non-consolidated fractures, cognitive deficits limiting communication).
* Contractures of fixed joints that limit the range of motion of the orthoses
* Inability to properly adjust the harness and/or orthoses
3 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Centri di Riabilitazione Padre Pio Onlus - Gli Angeli di Padre Pio
UNKNOWN
G. d'Annunzio University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniela Cardone
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniela Cardone, Dr
Role: PRINCIPAL_INVESTIGATOR
G. d'Annunzio University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Centri di Riabilitazione Padre Pio Onlus - Gli Angeli di Padre Pio
San Giovanni Rotondo, FG, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D53D23021770001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.